One Health approach to Nipah virus prevention

Q3 Medicine Vacunas Pub Date : 2024-04-01 DOI:10.1016/j.vacun.2024.02.002
Muhammad Safdar , Shafeeq ur Rehman , Muhammad Younus , Muhammad Arif Rizwan , Muhammad Kaleem , Mehmet Ozaslan
{"title":"One Health approach to Nipah virus prevention","authors":"Muhammad Safdar ,&nbsp;Shafeeq ur Rehman ,&nbsp;Muhammad Younus ,&nbsp;Muhammad Arif Rizwan ,&nbsp;Muhammad Kaleem ,&nbsp;Mehmet Ozaslan","doi":"10.1016/j.vacun.2024.02.002","DOIUrl":null,"url":null,"abstract":"<div><p>The Nipah virus (NiV) is a highly lethal disease, resulting in a mortality rate of 75%. Outbreaks have been observed in southeast Asian countries, including Singapore, Malaysia, Bangladesh, and India. As of September 24, 2023, 6 confirmed cases of the NiV had been reported, including 2 fatalities in the Kozhikode District in Northern Kerala, India. In January and February of 2023, this virus sparked an epidemic in Bangladesh. Bats are important hosts for zoonotic viruses such as the NiV, SARS-CoV-2, Ebola virus, and others; nevertheless, relatively little is known about the ecological determinants and dynamics of these viruses' propagation in their reservoir hosts. Therefore, this review assessed early detection, data integration, community awareness, and resource limitations. Moreover, it gives specific future directions, emphasizing the urgency of vaccine and antiviral development, genomic surveillance advancements, case studies, healthcare system reinforcement, and intensified global collaboration. By addressing these issues, the One Health approach emerges as a vital and proactive strategy for NiV prevention, ensuring comprehensive preparedness and response mechanisms against future outbreaks.</p></div>","PeriodicalId":53407,"journal":{"name":"Vacunas","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Vacunas","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1576988724000207","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

The Nipah virus (NiV) is a highly lethal disease, resulting in a mortality rate of 75%. Outbreaks have been observed in southeast Asian countries, including Singapore, Malaysia, Bangladesh, and India. As of September 24, 2023, 6 confirmed cases of the NiV had been reported, including 2 fatalities in the Kozhikode District in Northern Kerala, India. In January and February of 2023, this virus sparked an epidemic in Bangladesh. Bats are important hosts for zoonotic viruses such as the NiV, SARS-CoV-2, Ebola virus, and others; nevertheless, relatively little is known about the ecological determinants and dynamics of these viruses' propagation in their reservoir hosts. Therefore, this review assessed early detection, data integration, community awareness, and resource limitations. Moreover, it gives specific future directions, emphasizing the urgency of vaccine and antiviral development, genomic surveillance advancements, case studies, healthcare system reinforcement, and intensified global collaboration. By addressing these issues, the One Health approach emerges as a vital and proactive strategy for NiV prevention, ensuring comprehensive preparedness and response mechanisms against future outbreaks.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
预防尼帕病毒的 "一种健康 "方法
尼帕病毒(NiV)是一种高度致命的疾病,死亡率高达 75%。新加坡、马来西亚、孟加拉国和印度等东南亚国家都爆发过疫情。截至 2023 年 9 月 24 日,印度喀拉拉邦北部的科济科德地区共报告了 6 例 NiV 确诊病例,其中 2 例死亡。2023 年 1 月和 2 月,这种病毒在孟加拉国引发了一场流行病。蝙蝠是NiV、SARS-CoV-2、埃博拉病毒等人畜共患病毒的重要宿主;然而,人们对这些病毒在宿主体内传播的生态决定因素和动态却知之甚少。因此,本综述对早期检测、数据整合、社区意识和资源限制进行了评估。此外,它还给出了未来的具体方向,强调了疫苗和抗病毒开发、基因组监测进展、案例研究、医疗保健系统强化和加强全球合作的紧迫性。通过解决这些问题,"一体健康 "方法将成为预防尼罗河病毒的一项重要而积极的战略,确保针对未来疫情爆发的全面准备和响应机制。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Vacunas
Vacunas Medicine-Infectious Diseases
CiteScore
3.90
自引率
0.00%
发文量
138
审稿时长
62 days
期刊介绍: Sin duda una de las mejores publicaciones para conocer los avances en el campo de las vacunaciones preventivas, tanto en el ámbito de la investigación básica como aplicada y en la evaluación de programas de vacunaciones. Su alta calidad y utilidad la ha llevado a estar indexada en los prestigiosos índices IME y SCOPUS.
期刊最新文献
Revisión de los formatos de presentación de vacunas y sus principales características Plant system as a versatile and robust platform for the development of vaccines against arboviral infections Designing an immuno-epitope candidate vaccine from (Opa, ProA, ProB, RmpM and BamD) proteins against Neisseria gonorrhoeae and Neisseria meningitides Acceptance of malaria vaccine among mothers of under-five children in Nigeria: Results from the M-VAN survey Association of C4 and CH50 levels with cough and rhinorrhea in COVID-19 patients: A retrospective analysis in the Iranian population
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1